{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:39:28Z","timestamp":1788205168220,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,4,5]]},"abstract":"<jats:title>\n                    <jats:bold>Abstract<\/jats:bold>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Whole Transcriptome Sequencing (WTS) is a comprehensive alternative to targeted panels for detecting gene fusions and splice variants. To integrate WTS into clinical diagnostics, we compared its performance against established fusion assays (Archer FusionPlex and TSO500 RNA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>WTS was evaluated in an initial cohort of 64 FFPE tumor samples, and quality control (QC) thresholds were defined based on missed fusions correlating with low tumor cell content (TCC\u2009&lt;\u200940%). Key QC metrics included TCC\u2009\u2265\u200940%, RNA input \u226550\u2009ng, \u226550 million reads, and median insert size &gt;100\u2009bp.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>WTS identified 92% of known fusions in the initial cohort. Validation in 357 samples showed 100% concordance with panel-based results when QC thresholds were met. Subsequent clinical deployment across 812 diverse tumor cases detected 121 fusions, though 423 (34%) required fallback to targeted assays due to low TCC. WTS provided added value by detecting novel fusions, pathogens, and enabling oncogenic pathway analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>WTS is a reliable and informative method for fusion and splice variant detection in clinical diagnostics, provided rigorous pre-analytical and sequencing QC metrics are strictly applied.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-025-03307-8","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:20:10Z","timestamp":1768346410000},"page":"1101-1110","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples"],"prefix":"10.1038","volume":"134","author":[{"given":"Markus","family":"Ball","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Wlochowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Zgorzelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Pallares Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Allg\u00e4uer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lena","family":"Volckmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Goldschmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-5617","authenticated-orcid":false,"given":"Iordanis","family":"Ourailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7966-8980","authenticated-orcid":false,"given":"Petros","family":"Christopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huriye","family":"Seker-Cin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Schnecko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2684-9187","authenticated-orcid":false,"given":"Olaf","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4129-4741","authenticated-orcid":false,"given":"Michael","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoas","family":"Fioretos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schirmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6668-5327","authenticated-orcid":false,"given":"Jan","family":"Budczies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1001-103X","authenticated-orcid":false,"given":"Albrecht","family":"Stenzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-3281","authenticated-orcid":false,"given":"Daniel","family":"Kazdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"3307_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.celrep.2018.03.050","volume":"23","author":"Q Gao","year":"2018","unstructured":"Gao Q, Liang WW, Foltz SM, Mutharasu G, Jayasinghe RG, Cao S, et al. Driver fusions and their implications in the development and treatment of human cancers. Cell Rep. 2018;23:227\u201338.e3.","journal-title":"Cell Rep"},{"key":"3307_CR2","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290\u20133.","journal-title":"Nature"},{"key":"3307_CR3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1056\/NEJM198810133191506","volume":"319","author":"R Kurzrock","year":"1988","unstructured":"Kurzrock R, Gutterman JU, Talpaz M. The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med. 1988;319:990\u20138.","journal-title":"N Engl J Med"},{"key":"3307_CR4","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.3390\/molecules25081864","volume":"25","author":"NM Chrzanowska","year":"2020","unstructured":"Chrzanowska NM, Kowalewski J, Lewandowska MA. Use of Fluorescence In Situ Hybridization (FISH) in diagnosis and tailored therapies in solid tumors. Molecules. 2020;25:1864.","journal-title":"Molecules"},{"key":"3307_CR5","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1007\/s11033-021-06963-0","volume":"49","author":"S Ergin","year":"2022","unstructured":"Ergin S, Kherad N, Alagoz M. RNA sequencing and its applications in cancer and rare diseases. Mol Biol Rep. 2022;49:2325\u201333.","journal-title":"Mol Biol Rep"},{"key":"3307_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1100352","volume":"14","author":"M Tsakiroglou","year":"2023","unstructured":"Tsakiroglou M, Evans A, Pirmohamed M. Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis. Front Genet. 2023;14:1100352.","journal-title":"Front Genet"},{"key":"3307_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/gcc.23022","volume":"61","author":"D Kazdal","year":"2022","unstructured":"Kazdal D, Hofman V, Christopoulos P, Ilie M, Stenzinger A, Hofman P. Fusion-positive non-small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications. Genes Chromosomes Cancer. 2022;61:244\u201360.","journal-title":"Genes Chromosomes Cancer"},{"key":"3307_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s13045-020-01005-x","volume":"13","author":"M Hong","year":"2020","unstructured":"Hong M, Tao S, Zhang L, Diao LT, Huang X, Huang S, et al. RNA sequencing: new technologies and applications in cancer research. J Hematol Oncol. 2020;13:166.","journal-title":"J Hematol Oncol"},{"key":"3307_CR9","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/cancers11091309","volume":"11","author":"M Kirchner","year":"2019","unstructured":"Kirchner M, Neumann O, Volckmar AL, Stogbauer F, Allgauer M, Kazdal D, et al. RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer Samples. Cancers. 2019;11:1309.","journal-title":"Cancers"},{"key":"3307_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-00909-y","volume":"14","author":"C Heydt","year":"2021","unstructured":"Heydt C, Wolwer CB, Velazquez Camacho O, Wagener-Ryczek S, Pappesch R, Siemanowski J, et al. Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation. BMC Med Genomics. 2021;14:62.","journal-title":"BMC Med Genomics"},{"key":"3307_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrg.2016.10","volume":"17","author":"SA Byron","year":"2016","unstructured":"Byron SA, Van Keuren-Jensen KR, Engelthaler DM, Carpten JD, Craig DW. Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat Rev Genet. 2016;17:257\u201371.","journal-title":"Nat Rev Genet"},{"key":"3307_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semcancer.2021.07.003","volume":"84","author":"V Jobanputra","year":"2022","unstructured":"Jobanputra V, Wrzeszczynski KO, Buttner R, Caldas C, Cuppen E, Grimmond S, et al. Clinical interpretation of whole-genome and whole-transcriptome sequencing for precision oncology. Semin Cancer Biol. 2022;84:23\u201331.","journal-title":"Semin Cancer Biol"},{"key":"3307_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113379","volume":"195","author":"C Bosi","year":"2023","unstructured":"Bosi C, Bartha A, Galbardi B, Notini G, Naldini MM, Licata L, et al. Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response. Eur J Cancer. 2023;195:113379.","journal-title":"Eur J Cancer"},{"key":"3307_CR14","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453\u2013457.","journal-title":"Nat Methods"},{"key":"3307_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17:218.","journal-title":"Genome Biol"},{"key":"3307_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","volume":"5","author":"P Danaher","year":"2017","unstructured":"Danaher P, Warren S, Dennis L, D\u2019Amico L, White A, Disis ML, et al. Gene expression markers of Tumor Infiltrating Leukocytes. J Immunother Cancer. 2017;5:18.","journal-title":"J Immunother Cancer"},{"key":"3307_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1860586","volume":"10","author":"J Budczies","year":"2021","unstructured":"Budczies J, Kirchner M, Kluck K, Kazdal D, Glade J, Allgauer M, et al. A gene expression signature associated with B cells predicts benefit from immune checkpoint blockade in lung adenocarcinoma. Oncoimmunology. 2021;10:1860586.","journal-title":"Oncoimmunology"},{"key":"3307_CR18","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.3389\/fgene.2019.01152","volume":"10","author":"G Marco-Puche","year":"2019","unstructured":"Marco-Puche G, Lois S, Benitez J, Trivino JC. RNA-seq perspectives to improve clinical diagnosis. Front Genet. 2019;10:1152.","journal-title":"Front Genet"},{"key":"3307_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08635-5","volume":"21","author":"W Walter","year":"2021","unstructured":"Walter W, Shahswar R, Stengel A, Meggendorfer M, Kern W, Haferlach T, et al. Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia. BMC Cancer. 2021;21:886.","journal-title":"BMC Cancer"},{"key":"3307_CR20","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00504","volume":"6","author":"JY Hehir-Kwa","year":"2022","unstructured":"Hehir-Kwa JY, Koudijs MJ, Verwiel ETP, Kester LA, van Tuil M, Strengman E, et al. Improved gene fusion detection in childhood cancer diagnostics using RNA sequencing. JCO Precis Oncol. 2022;6:e2000504.","journal-title":"JCO Precis Oncol"},{"key":"3307_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1101\/gr.257246.119","volume":"31","author":"S Uhrig","year":"2021","unstructured":"Uhrig S, Ellermann J, Walther T, Burkhardt P, Frohlich M, Hutter B, et al. Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res. 2021;31:448\u201360.","journal-title":"Genome Res"},{"key":"3307_CR22","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/nprot.2013.084","volume":"8","author":"BJ Haas","year":"2013","unstructured":"Haas BJ, Papanicolaou A, Yassour M, Grabherr M, Blood PD, Bowden J, et al. De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis. Nat Protoc. 2013;8:1494\u2013512.","journal-title":"Nat Protoc"},{"key":"3307_CR23","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.1002\/cam4.4686","volume":"11","author":"NV Mitiushkina","year":"2022","unstructured":"Mitiushkina NV, Romanko AA, Preobrazhenskaya EV, Tiurin VI, Ermachenkova TI, Martianov AS, et al. Comprehensive evaluation of the test for 5\u2019-\/3\u2019-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer. Cancer Med. 2022;11:3226\u201337.","journal-title":"Cancer Med"},{"key":"3307_CR24","unstructured":"Mitelman F J BaMFE. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. https:\/\/mitelmandatabaseisb-cgcorg 2025."},{"key":"3307_CR25","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00180-017-0740-4","volume":"33","author":"S Fasola","year":"2018","unstructured":"Fasola S, Muggeo VMR, K\u00fcchenhoff H. A heuristic, iterative algorithm for change-point detection in abrupt change models. Comput Stat. 2018;33:997\u20131015.","journal-title":"Comput Stat"},{"key":"3307_CR26","unstructured":"RCoreTeam. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna. https:\/\/www.R-projectorg 2021."},{"key":"3307_CR27","doi-asserted-by":"publisher","first-page":"e1006266","DOI":"10.1371\/journal.pcbi.1006266","volume":"14","author":"CC Wu","year":"2018","unstructured":"Wu CC, Beird HC, Zhang J, Futreal PA. FusionPathway: prediction of pathways and therapeutic targets associated with gene fusions in cancer. PLoS Comput Biol. 2018;14:e1006266.","journal-title":"PLoS Comput Biol"},{"key":"3307_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-1-4939-0512-6_9","volume":"1150","author":"A Liberzon","year":"2014","unstructured":"Liberzon A. A description of the Molecular Signatures Database (MSigDB) Web site. Methods Mol Biol. 2014;1150:153\u2013160.","journal-title":"Methods Mol Biol"},{"key":"3307_CR29","unstructured":"Korotkevich G SV, Sergushichev A. Fast gene set enrichment analysis. bioRxiv 101101\/060012, https:\/\/biorxivorg\/content\/early\/2016\/06\/20\/060012 2019."},{"key":"3307_CR30","doi-asserted-by":"crossref","unstructured":"Love MI HW, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"3307_CR31","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao Y, Smyth GK, Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 2013;41:e108.","journal-title":"Nucleic Acids Res"},{"key":"3307_CR32","first-page":"4","volume":"2","author":"Martijn","year":"2023","unstructured":"Martijn, Tennekes PE. A treemap is a space-filling visualization of hierarchical structures. Version. 2023;2:4\u20134.","journal-title":"Version"},{"key":"3307_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20:257.","journal-title":"Genome Biol"},{"key":"3307_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-385","volume":"12","author":"BD Ondov","year":"2011","unstructured":"Ondov BD, Bergman NH, Phillippy AM. Interactive metagenomic visualization in a Web browser. BMC Bioinforma. 2011;12:385.","journal-title":"BMC Bioinforma"},{"key":"3307_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24\u20136.","journal-title":"Nat Biotechnol"},{"key":"3307_CR36","doi-asserted-by":"crossref","unstructured":"Wickham H. ggplot2- Elegant graphics for data analysis: Springer Cham; 2016.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"3307_CR37","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32:2847\u20139.","journal-title":"Bioinformatics"},{"key":"3307_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.gde.2017.10.007","volume":"48","author":"MW Popp","year":"2018","unstructured":"Popp MW, Maquat LE. Nonsense-mediated mRNA decay and cancer. Curr Opin Genet Dev. 2018;48:44\u201350.","journal-title":"Curr Opin Genet Dev"},{"key":"3307_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419.","journal-title":"Science"},{"key":"3307_CR40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/1878-0261.13348","volume":"17","author":"Z Wang","year":"2023","unstructured":"Wang Z, Han Y, Tao H, Xu M, Liu Z, Zhu J, et al. Molecular characterization of genomic breakpoints of ALK rearrangements in non-small cell lung cancer. Mol Oncol. 2023;17:765\u201378.","journal-title":"Mol Oncol"},{"key":"3307_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-419","volume":"15","author":"W Zhao","year":"2014","unstructured":"Zhao W, He X, Hoadley KA, Parker JS, Hayes DN, Perou CM. Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling. BMC Genomics. 2014;15:419.","journal-title":"BMC Genomics"},{"key":"3307_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23226-4","volume":"8","author":"S Zhao","year":"2018","unstructured":"Zhao S, Zhang Y, Gamini R, Zhang B, von Schack D. Evaluation of two main RNA-seq approaches for gene quantification in clinical RNA sequencing: polyA+ selection versus rRNA depletion. Sci Rep. 2018;8:4781.","journal-title":"Sci Rep"},{"key":"3307_CR43","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1101\/gr.189621.115","volume":"25","author":"M Cieslik","year":"2015","unstructured":"Cieslik M, Chugh R, Wu YM, Wu M, Brennan C, Lonigro R, et al. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing. Genome Res. 2015;25:1372\u201381.","journal-title":"Genome Res"},{"key":"3307_CR44","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.21037\/tlcr-20-1168","volume":"10","author":"D Kazdal","year":"2021","unstructured":"Kazdal D, Rempel E, Oliveira C, Allgauer M, Harms A, Singer K, et al. Conventional and semi-automatic histopathological analysis of tumor cell content for multigene sequencing of lung adenocarcinoma. Transl Lung Cancer Res. 2021;10:1666\u201378.","journal-title":"Transl Lung Cancer Res"},{"key":"3307_CR45","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/modpathol.2013.95","volume":"26","author":"HU Schildhaus","year":"2013","unstructured":"Schildhaus HU, Deml KF, Schmitz K, Meiboom M, Binot E, Hauke S, et al. Chromogenic hybridization is a reliable assay for detection of rearrangements in adenocarcinomas of the lung. Mod Pathol. 2013;26:1468\u201377.","journal-title":"Mod Pathol"}],"updated-by":[{"DOI":"10.1038\/s41416-026-03360-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000}}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03307-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03307-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03307-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:23:32Z","timestamp":1773771812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03307-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,5]]}},"alternative-id":["3307"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03307-8","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: In this article, the author\u2019s name, Olaf Neumann, was incorrectly written as Olaf Neuman.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41416-026-03360-x","URL":"https:\/\/doi.org\/10.1038\/s41416-026-03360-x","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MB, SB, DW, TF, KL, CZ, APR, MA, AV, HG, IO, RB, HS, AF, FS, ON, MM report: no conflicts of interest. PC reports: Institutional Funding: Roche, Amgen, Boehringer Ingelheim, Takeda, Merck, AstraZeneca, Novartis. Advisory Board \/ Speaker\u2019s Honoraria: Takeda, Gilead, AstraZeneca, Thermo Fisher, Janssen, Pfizer, Novartis, Daiichi Sankyo, Eli Lilly, Pfizer, Chugai, Boehringer Ingelheim, Takeda, Novartis, AstraZeneca, MSD, Roche. MT reports: Advisory Board: Amgen, AstraZeneca, Beigene, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Gilead Sciences, GlaxoSmithKline, Johnson&Johnson, Lilly, Merck, MSD, Novartis, Pfizer, Pharmamar, Pierre Fabre, Regeneron, Roche, Sanofi, Takeda. Institutional Funding: AstraZeneca, Bristol-Myers Squibb, Johnson&Johnson, Merck, Pharmamar, Roche, Takeda. MK reports: Speaker\u2019s Honoraria: Veracyte Inc. TF reports: Financial Interest: Co-founder, board member, and owns stocks in Qlucore AB, Lund, Sweden. PS reports: Institutional Funding: Bayer, BMS, Chugai, Incyte, MSD. SP reports: Consultation\/Advisory: AbbVie, Amgen, Arcus, AstraZeneca, Bayer, Beigene, BerGenBio, Biocartis, BioInvent, Blueprint Medicines, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F-Star, Fishawack, Foundation Medicine, Genzyme, Gilead, GSK, Hutchmed, Illumina, Incyte, Ipsen, iTeos, Janssen, Merck Sharp and Dohme, Merck Serono, Merrimack, Mirati, Nykode Therapeutics, Novartis, Novocure, Pharma Mar, Promontory Therapeutics, Pfizer, Regeneron, Roche\/Genentech, Sanofi, Seattle Genetics, Takeda. JB reports: Institutional Funding: German Cancer Aid, MSD. AS reports: Advisory Board\/Speaker\u2019s Honoraria: Agilent, Aignostics, Amgen, Astellas, Astra Zeneca, Bayer, BMS, Eli Lilly, Illumina, Incyte, Janssen, MSD, Novartis, Pfizer, Qlucore, QuiP, Roche, Sanofi, Seagen, Servier, Takeda, Thermo Fisher. Institutional Funding: Bayer, BMS, Chugai, Incyte, MSD. DK reports: Speaker\u2019s Honoraria\/Advisory Board: AstraZeneca, Bristol-Myers Squibb, Pfizer, Lilly, Agilent, Takeda.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}